Here, in agreement with the causal role of IL23 signaling in autoimmune diseases, GWAS and fine-mapping experiments suggest that strategies that directly inhibit the IL23 receptor (IL23R) could be of even greater potential therapeutic value.34 The gene discussed is IL23R; the disease is autoimmune disease.